BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15531928)

  • 1. Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis.
    Li C; Lin M; Liu J
    Oncogene; 2004 Dec; 23(58):9336-47. PubMed ID: 15531928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of oncostatin M-induced growth arrest of MCF-7 cells expressing a temperature-sensitive mutant of p53.
    Li C; Shridhar K; Liu J
    Breast Cancer Res Treat; 2003 Jul; 80(1):23-37. PubMed ID: 12889596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis.
    Sadasivam S; Gupta S; Radha V; Batta K; Kundu TK; Swarup G
    Oncogene; 2005 Jan; 24(4):627-36. PubMed ID: 15580302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y.
    Faniello MC; Di Sanzo M; Quaresima B; Baudi F; Di Caro V; Cuda G; Morrone G; Del Sal G; Spinelli G; Venuta S; Costanzo F
    Int J Biochem Cell Biol; 2008; 40(10):2110-9. PubMed ID: 18372207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
    Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.
    Kurdistani SK; Arizti P; Reimer CL; Sugrue MM; Aaronson SA; Lee SW
    Cancer Res; 1998 Oct; 58(19):4439-44. PubMed ID: 9766676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53-dependent suppression of uridine phosphorylase gene expression through direct promoter interaction.
    Zhang D; Cao D; Russell R; Pizzorno G
    Cancer Res; 2001 Sep; 61(18):6899-905. PubMed ID: 11559567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P130 and its truncated form mediate p53-induced cell cycle arrest in Rb(-/-) Saos2 cells.
    Gao CF; Ren S; Wang J; Zhang SL; Jin F; Nakajima T; Ikeda M; Tsuchida N
    Oncogene; 2002 Oct; 21(49):7569-79. PubMed ID: 12386819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity.
    Liu X; Yue P; Khuri FR; Sun SY
    Cancer Res; 2005 Oct; 65(20):9169-75. PubMed ID: 16230375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
    Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
    Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
    Mirza A; Wu Q; Wang L; McClanahan T; Bishop WR; Gheyas F; Ding W; Hutchins B; Hockenberry T; Kirschmeier P; Greene JR; Liu S
    Oncogene; 2003 Jun; 22(23):3645-54. PubMed ID: 12789273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-MYB is required for recovery from the DNA damage-induced G2 checkpoint in p53 mutant cells.
    Mannefeld M; Klassen E; Gaubatz S
    Cancer Res; 2009 May; 69(9):4073-80. PubMed ID: 19383908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by vinblastine via c-Jun autoamplification and p53-independent down-regulation of p21WAF1/CIP1.
    Kolomeichuk SN; Bene A; Upreti M; Dennis RA; Lyle CS; Rajasekaran M; Chambers TC
    Mol Pharmacol; 2008 Jan; 73(1):128-36. PubMed ID: 18094076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p130/p107/p105Rb-dependent transcriptional repression during DNA-damage-induced cell-cycle exit at G2.
    Jackson MW; Agarwal MK; Yang J; Bruss P; Uchiumi T; Agarwal ML; Stark GR; Taylor WR
    J Cell Sci; 2005 May; 118(Pt 9):1821-32. PubMed ID: 15827088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-Independent activation of the gadd45 promoter by Delta12-prostaglandin J2.
    Ohtani-Fujita N; Minami S; Mimaki S; Dao S; Sakai T
    Biochem Biophys Res Commun; 1998 Oct; 251(2):648-52. PubMed ID: 9792828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Spot 14 protein is a p53-dependent transcriptional coactivator via the recruitment of thyroid receptor and Zac1.
    Chou WY; Ho CL; Tseng ML; Liu ST; Yen LC; Huang SM
    Int J Biochem Cell Biol; 2008; 40(9):1826-34. PubMed ID: 18299245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of p53 by Pitx1.
    Liu DX; Lobie PE
    Cell Death Differ; 2007 Nov; 14(11):1893-907. PubMed ID: 17762884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mitotic spindle checkpoint protein hsMAD1 correlates with cellular proliferation and is activated by a gain-of-function p53 mutant.
    Iwanaga Y; Jeang KT
    Cancer Res; 2002 May; 62(9):2618-24. PubMed ID: 11980658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.